This episode features a panel that I moderated in front of a standing-room-only crowd at the Milken Institute's Global Conference 2019. It includes a great overview of psychedelic science, investing opportunities, anecdotal personal benefits, legal challenges, and much more. I think it's one of the more comprehensive panels ever done on the subject. Here are the participants:Matthew Johnson — Principal Investigator, Johns Hopkins Psychedelic Research UnitAyelet Waldman — Author, A Really Good Day: How Microdosing Made a Mega Difference in My Mood, My Marriage, and My LifeRobin Carhart-Harris — Head of Psychedelic Research, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College LondonChristian Angermayer — Founder, Apeiron Investment Group and ATAI Life SciencesPlease enjoy!
Comments